🫀 Cardiovascular Update: Stroke Therapy Trial Approval, AI-Powered Heart Disease Screening, Robotic Surgery Breakthrough and More
Stay updated with the latest developments in cardiovascular research! In this video, we dive into the groundbreaking advancements shaping the future of heart and stroke care, from AI-powered tools to cutting-edge treatments.
📌 In This Episode:
💉 GNT Pharma’s regulatory approval for a global Phase 3 trial of Nelonemdaz for stroke therapy.
🧠 An AI system, EchoNext, that turns routine ECG tests into life-saving tools for heart disease detection.
🚀 A $5M grant to Kaiser Permanente to enhance heart failure care using AI-powered heart ultrasounds.
💰 Eli Lilly’s acquisition of Verve Therapeutics, aiming to reduce cardiovascular risk with genetic therapies.
🏥 Innovative AI applications in heart ultrasound technology improving cardiac care.
🌍 The successful completion of an intercontinental robotic cardiac surgery.
💉 Pharmazz enrolling the first patient in a Phase 3 trial for Sovateltide in treating cerebral ischemic stroke.
🧬 Japan’s first clinical iPS cell heart transplant for treating dilated cardiomyopathy.
💡 Combination therapies using GLP-1 receptor agonists and SGLT2 inhibitors showing positive results for ASCVD and heart failure.
🧠 The AI4HF project working on personalizing heart failure treatment.
💉 The progress of Pharmazz’s stroke treatment under the FDA’s Special Protocol Assessment.
📢 Stay Ahead in Cardiovascular Research!
✅ Like, share, and subscribe for weekly updates on heart failure, AFib, stroke, and more
#CardiovascularResearch #HeartDisease #StrokeTreatment #AIinHealthcare #MedicalInnovation #Cardiology #HeartFailure #ClinicalTrials #Neuroprotection #AIinMedicine #CardiacCare